SCHEMBL21168137

SCHEMBL21168137

FC(F)(F)C(c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1)(c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)ccc32)cc1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGER4 P35408 1/20 0.37
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ABCG2 Q9UNQ0 4/20 0.34
MAT2A P31153 1/20 0.33
TEAD1 P28347 1/20 0.33
TEAD4 Q15561 1/20 0.33
TEAD2 Q15562 1/20 0.33
TEAD3 Q99594 1/20 0.33
RAC2 P15153 1/20 0.33
RAC3 P60763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21168056 1.00 KDM4E (0.42) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168158 0.94 KDM4E (0.39) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168177 0.94 KDM4E (0.39) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168098 0.94 KDM4E (0.39) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168255 0.94 KDM4E (0.39) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168057 0.94 KDM4E (0.40) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168132 0.94 KDM4E (0.40) KDM4EATML3MBTL1PTGER4MGAM
SCHEMBL21168135 0.93 ATM (0.45) KDM4EATML3MBTL1MGAMGAA
SCHEMBL21168245 0.93 ATM (0.45) KDM4EATML3MBTL1MGAMGAA
SCHEMBL21168182 0.90 KDM4E (0.43) KDM4EATML3MBTL1MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225147-A1 ORGANIC LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-07-13 US disclosed
US-20230225147-A1 ORGANIC LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-07-13 US disclosed
US-11637244-B2 Light-emitting material, compound, and organic light-emitting element KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-04-25 US disclosed
US-20200259112-A1 ORGANIC LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2020-08-13 US disclosed
US-20190221749-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11637244-B2 Light-emitting material, compound, and organic light-emitting element RPLP2, OPRD1, POLL KDM4E 3856/4885ATM 3694/4885L3MBTL1 410/4885
US-20190221749-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT SLC43A1, SLC7A5, SLC39A3 KDM4E 4193/4885ATM 1500/4885L3MBTL1 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.